Overview

• A groundbreaking blood test has been developed to predict dementia up to 15 years before diagnosis, offering hope for early intervention.
• Scientists have discovered 11 proteins that accurately predict dementia in more than 90% of cases, marking a significant advancement in detection.
• The test could enable the effective use of new Alzheimer's drugs, such as donanemab and lecanemab, which require early diagnosis for optimal results.
• The UK's NHS is considered for integrating the test as a routine screening tool, highlighting its potential for widespread implementation.
• Concerns remain about the current lack of early diagnosis and the need for healthcare system adjustments to accommodate new treatments.